A review of documentation relating to a clinical trial of the epilepsy drug gabapentin suggests that the study may have been a “seeding trial” used to promote the drug and increase prescribing, according to a new report.
A review of documentation relating to a clinical trial of the epilepsy drug gabapentin suggests that the study may have been a “seeding trial” used to promote the drug and increase prescribing, according to a new report.